INmune Bio Advances CORDStrom Toward Rare Disease Commercialization
at www.tipranks.com (Fri, 13-Feb 4:45 PM)
INmune Bio: Biomarker-Driven Alzheimer’s Trial Design and Pipeline Catalysts Underpin Buy Rating
at www.tipranks.com (Fri, 13-Feb 3:15 PM)
